We are live on ! Find out more
TC

TFS Capital Portfolio holdings

AUM $255M
1-Year Est. Return 32.31%
This Fund
S&P 500
This Quarter Est. Return
+5.75%
1 Year Est. Return
+32.31%
3 Year Est. Return
+53.79%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$929M
AUM Growth
-$109M
Cap. Flow
-$118M
Cap. Flow %
-12.66%
Top 10 Hldgs %
7.01%
Holding
1,130
New
256
Increased
201
Reduced
274
Closed
399

Top Buys

Rank Stock Value
1
UPBD icon
Upbound Group
UPBD
+$7.28M
2
RAIL icon
FreightCar America
RAIL
+$5.96M
3
CPHD
Cepheid Inc
CPHD
+$5.77M
4
DBRG icon
DigitalBridge
DBRG
+$5.69M
5
SPXC icon
SPX Corp
SPXC
+$5.56M

Top Sells

Rank Stock Value
1
PLUS icon
ePlus
PLUS
+$7.35M
2
CNCE
Concert Pharmaceuticals, Inc.
CNCE
+$6.04M
3
MTOR
MERITOR, Inc.
MTOR
+$5.88M
4
HZO icon
MarineMax
HZO
+$5.63M
5
WOR icon
Worthington Enterprises
WOR
+$5.63M

Sector Composition

Rank Sector Weight
1 Healthcare 22.43%
2 Technology 14.1%
3 Industrials 13.01%
4 Consumer Discretionary 12.84%
5 Financials 6.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WYY icon
726
WidePoint Corp
WYY
$106M
$21K ﹤0.01%
2,979
-3,819
-56% -$30.8K
ATRS
727
DELISTED
Antares Pharma, Inc.
ATRS
$21K ﹤0.01%
17,642
-122,000
-87% -$170K
FLNA
728
Filana Therapeutics
FLNA
$43.5M
$20K ﹤0.01%
1,643
-325
-17% -$4.3K
VMEM
729
DELISTED
VIOLIN MEMORY, INC.
VMEM
$14K ﹤0.01%
+3,796
New +$20K
QUIK icon
730
QuickLogic
QUIK
$228M
$12K ﹤0.01%
748
-80
-10% -$1.53K
MDGL icon
731
Madrigal Pharmaceuticals
MDGL
$12.7B
$11K ﹤0.01%
914
-9,582
-91% -$263K
ABCB icon
732
Ameris Bancorp
ABCB
$5.77B
– –
-23,205
Closed -$667K
ACIC icon
733
American Coastal Insurance
ACIC
$505M
– –
-22,935
Closed -$302K
ADC icon
734
Agree Realty
ADC
$9.66B
– –
-33,194
Closed -$991K
ADUS icon
735
Addus HomeCare
ADUS
$2.16B
– –
-103,110
Closed -$3.21M
ADVM
736
DELISTED
Adverum Biotechnologies
ADVM
– –
-3,563
Closed -$294K
AFB
737
AllianceBernstein National Municipal Income Fund
AFB
$314M
– –
-14,800
Closed -$197K
AIT icon
738
Applied Industrial Technologies
AIT
$12.9B
– –
-33,337
Closed -$1.27M
AIV
739
Aimco
AIV
$377M
– –
-160,248
Closed -$790K
ALTO icon
740
Alto Ingredients
ALTO
$349M
– –
-116,552
Closed -$756K
AMED
741
DELISTED
Amedisys
AMED
– –
-54,923
Closed -$2.08M
AMN icon
742
AMN Healthcare
AMN
$1.3B
– –
-45,031
Closed -$1.35M
ANDE icon
743
Andersons Inc
ANDE
$2.54B
– –
-55,558
Closed -$1.89M
APOG icon
744
Apogee Enterprises
APOG
$855M
– –
-20,900
Closed -$933K
ARDC
745
Are Dynamic Credit Allocation Fund
ARDC
$296M
– –
-17,548
Closed -$245K
ASPN icon
746
Aspen Aerogels
ASPN
$385M
– –
-28,793
Closed -$216K
AVK
747
Advent Convertible and Income Fund
AVK
$543M
– –
-31,221
Closed -$400K
DCH
748
Dauch Corp
DCH
$1.32B
– –
-199,480
Closed -$3.98M
BCO icon
749
Brink's
BCO
$4.86B
– –
-87,271
Closed -$2.36M
BCRX icon
750
BioCryst Pharmaceuticals
BCRX
$2.43B
– –
-68,963
Closed -$786K
28 29
30
31 32

Similar funds

KC
KRV Capital New York $255M AUM 18.27% 1-Year Est. Return
IPC
Independent Portfolio Consultants Boca Raton, Florida $241M AUM 21.8% 1-Year Est. Return
ECPI
Energy Capital Partners III Summit, New Jersey $237M AUM
FRM
Fore Research & Management New York $221M AUM 2.93% 1-Year Est. Return
WFG
Windsor Financial Group Minneapolis, Minnesota $214M AUM 6.66% 1-Year Est. Return
IFB
iAB Financial Bank Fort Wayne, Indiana $204M AUM 19.19% 1-Year Est. Return
KL
Kinsight LLC Birmingham, Alabama $176M AUM 17.21% 1-Year Est. Return
RP
Ridgegate Proprietary Sydney, Australia $154M AUM 25.47% 1-Year Est. Return

TFS Capital's Q4 2015 Portfolio in Review

As of Q4 2015, TFS Capital held 1,130 positions worth $929M, down 10% from $1.04B the previous quarter. Its ten largest holdings account for 7% of the portfolio.

TFS Capital withdrew a net $118M in Q4 2015, closing 399 positions and reducing 274 holdings. Its most notable exit was ePlus, an estimated $7.35M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 18% a quarter earlier, followed by Technology and Industrials.

Against the trend, TFS Capital opened a new position in Upbound Group worth $5.71M.

  • TFS Capital's largest Q4 2015 buy was Upbound Group: 381,410 shares worth $5.71M.
  • TFS Capital added most to SPX Corp in Q4 2015, an estimated $5.56M increase.
  • TFS Capital's biggest Q4 2015 reduction was Concert Pharmaceuticals, Inc., cutting an estimated $6.04M.
  • TFS Capital fully exited ePlus in Q4 2015, selling an estimated $7.35M.
  • TFS Capital's ten largest holdings make up 7% of its $929M portfolio in Q4 2015.
  • TFS Capital opened 256 new positions and closed 399 in Q4 2015.
  • TFS Capital's portfolio value fell 10% quarter-over-quarter to $929M.

Based on TFS Capital's 13F filing for Q4 2015, filed 29 Jan 2016.